Focusing on 2026 as a starting point, PwC has laid out several “strategic imperatives” pharma companies ought to pursue this ...

After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond ...

The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping ...

The Biotechnology Innovation Organization’s CEO John Crowley isn’t shying away from the tough tasks. With only a little more than three months at the helm of the world’s largest biotech advocacy group ...

It has been a tough year for medicine. The U.S. research enterprise has been scrambled by a series of political decisions ...

NEW HAVEN, Conn.--(BUSINESS WIRE)--Weave Bio, an AI-native life sciences platform company, today announced that its AutoIND solution has received the “BioTech AI Innovation of the Year” award in the ...

Good morning. It’s an exciting week not only for biotech M&A, but also for my city (Chicago) as we gear up for our big game ...

China’s biotech sector is surging. For the first time, it now leads the world in clinical trials and new drug licensing. The U.S., once the undisputed leader in pharmaceutical innovation, risks losing ...

A Swedish startup aims to dominate stem cell production while nanotechnology is helping to transform cancer care. What does ...

For decades, the United States has led the world in biotech and pharmaceutical innovation. But our dominance is now at risk: not from external sabotage, but from our own regulatory sclerosis. While we ...

Explore the Latest Research Peptides from Biotech Labz Supply Sebastopol, United States – January 4, 2026 / Biotech Labz Supply / Biotech Labz Supply has revealed an exciting enhancement of its ...